wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55008089-18D4EC0F-7BF4-4EA3-A6C4-A59112B3E1BB
Q55008089-18D4EC0F-7BF4-4EA3-A6C4-A59112B3E1BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55008089-18D4EC0F-7BF4-4EA3-A6C4-A59112B3E1BB
Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes.
P2860
Q55008089-18D4EC0F-7BF4-4EA3-A6C4-A59112B3E1BB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55008089-18D4EC0F-7BF4-4EA3-A6C4-A59112B3E1BB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8493bb8cb7d84a861c924b628ae5f30a1026c4b5
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.